Interaction between SERTPR and stressful life events on response to antidepressant treatment

European Neuropsychopharmacology

Volumn 19, Issue 1, 2009, Pages 64-67

  Mandelli, Laura ^a   Marino, Elena ^b   Pirovano, Adele ^b   Calati, Raffaella ^a   Zanardi, Raffaella ^b   Colombo, Cristina ^b   Serretti, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Gene x environment interaction; Response to SSRIs; SERTPR; Stressful life events

Indexed keywords

FLUVOXAMINE; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; GENETIC POLYMORPHISM; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LIFE EVENT; LIFE STRESS; MAJOR CLINICAL STUDY; MOOD DISORDER; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIPOLAR DISORDER; DNA; FLUVOXAMINE; HUMANS; MOOD DISORDERS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STRESS, PSYCHOLOGICAL;

EID: 57049093901     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2008.08.005     Document Type: Article

References (22)

1. Brown, G. W., Harris, T. O., 1978. Unpublished manuscript, Bedford College, University of London.
2. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., Taylor A., and Poulton R. Science 297 (2002) 851-854
3. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., and Poulton R. Science 301 (2003) 386-389
4. Cohen J. Statistical power analysis for the behavioral sciences (1988), Lawrence Erlbaum Associates, Hillsdale, New Jersey
5. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. New York: Biometrics Research Department (1995), New York State Psychiatric Institute
6. Goodwin F., and Jamison K. Manic-depressive illness (1990), Oxford University Press, New York
7. Hamilton M. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
8. Heils A., Teufel A., Petri S., Stöber G., Riederer P., Bengel D., and Lesch P. J. Neurochem. 66 (1996) 2621-2624
9. Kaufman J., Yang B.Z., Douglas-Palumberi H., Houshyar S., Lipschitz D., Krystal J.H., and Gelernter J. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 17316-17321
10. Keller M.B., Lavori P.W., Friedman B., Nielsen E., Endicott J., McDonald-Scott P., and Andreasen N.C. Arch. Gen. Psychiatry 44 (1987) 540-548
11. Kendler K.S., Kessler R.C., Neale M.C., Heath A.C., and Eaves L.J. Am. J. Psychiatry 150 (1993) 1139-1148
12. Lahiri D.K., and Nurnberger J.I.J. Nucleic Acids Res. 19 (1991) 5444
13. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., and Weissman M.M. Arch. Gen. Psychiatry 39 (1982) 879-883
14. Mandelli L., Serretti A., Marino E., Pirovano A., Calati R., and Colombo C. Int. J. Neuropsychopharmacol. 10 (2007) 437-447
15. Serretti A., Artioli P., Lorenzi C., Pirovano A., Tubazio V., and Zanardi R. Int. J. Neuropsychopharmacol. 7 (2004) 453-460
16. Serretti A., Artioli P., and Quartesan R. Pharmacogenet. Genomics 15 (2005) 61-67
17. Serretti A., Calati R., Mandelli L., and De Ronchi D. Curr. Drug Targets 7 (2006) 1659-1669
18. Serretti A., Lilli R., Lorenzi C., Lattuada E., Cusin C., and Smeraldi E. Mol. Psychiatry 7 (2002) 95-99
19. Serretti A., Lilli R., and Smeraldi E. Eur. J. Pharmacol. 438 (2002) 117-128
20. Serretti A., Macciardi F., Cusin C., Lattuada E., Lilli R., and Smeraldi E. Psychiatry Res. 80 (1998) 129-136
21. Serretti A., Masaki K., De Ronchi D., and Kinoshita T. Mol. Psychiatry 12 (2007) 247-257
22. Winokur G. Mod. Probl. Pharmacopsychiatry 10 (1975) 1-11